Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Airway Epithelial Research

The Airway Epithelial Research Team is investigating the role of the epithelium in the development of airway diseases including asthma, cystic fibrosis and lung transplant rejection.

Understanding the importance of the regulatory mechanisms involved in each of these disease processes is essential if effective prevention and therapeutic strategies are to be developed.

In addition, they are also investigating the stem cells found in the lung and are examining their role in airway healing as well as other functions to try and identify areas for therapeutic targeting. This research has the potential to translate from the laboratory bench into clinical practice in the form of cellular therapy (alone or in combination with other therapies) and is a novel practical approach to treat airway disease.

The group has successfully established and optimized a primary cell in vitro model for each of these disease settings using airway cells recovered by a safe and routinely performed method. To our knowledge, we are only one of only a handful of laboratories to be performing this in children with asthma or cystic fibrosis, and the only lab that can compare samples with age and sex matched healthy controls.

Using our unique research program the team is not only able to study mechanisms underlying particular airway diseases but has developed functional outcome tests which enable them to conduct preclinical trials of potential new drugs as well as through the repurposing of currently available medications.

Team Highlights

  • Anthony Kicic- Research Star of 2018; National Scientific Leader in Pulmonology
  • Luke Garratt - FutureHealth WA Merit award
  • Luke Garratt- NHMRC Early career fellowship
  • Thomas Iosifidis – won TSANZ Young Investigator award
  • Kevin Looi – awarded travel award to attend iPSC workshop in Toronto Canada
  • Kevin Looi- TSANZ Astra Zenica- thoracic fellowship, Janet Elder TSANZ award
  • Thomas Iosifidis- TSANZ Janet Elder TSANZ award
  • Samuel Montgomery and Kelly Martinovich – awarded CFWA Top Up scholarship
  • Nicole Shaw- award PCH Foundation Top Up Award
  • Samuel Montgomery & Kak-Ming Ling- awarded UWA Research Travel Award

Team leader

Rothwell Family Fellow; Head, Airway Epithelial Research

Team members (17)

Thomas Iosifidis
Thomas Iosifidis

BSc BMedSci(Hons) PhD

Research Officer

Pamela Laird
Pamela Laird

BSc (physiotherapy) dist. PhD

Senior clinician research fellow

Luke Garratt

Luke Garratt

NHMRC Research Fellow

Jessica Hillas

Jessica Hillas

Research Assistant

Daniel Laucirica

Daniel Laucirica

Research Assistant; PhD Candidate

Kevin Looi

Kevin Looi

Research Officer

Kelly Martinovich

Kelly Martinovich

Research Assistant; PhD Candidate

Samantha McLean

Samantha McLean

Research Assistant

Kak Ming Ling

Kak Ming Ling

Research Assistant; PhD Candidate

Samuel Montgomery

Samuel Montgomery

Research Assistant; PhD Candidate

Matthew Poh

Matthew Poh

Research Assistant; PhD Candidate

Craig Schofield

Craig Schofield

Research Assistant

Nicole Shaw

Nicole Shaw

PhD Candidate

Erika Sutanto

Erika Sutanto

Senior Research Officer

Scott Winslow

Scott Winslow

Research Scientist

Renee Ng

Renee Ng

PhD Candidate

Andrew Vaitekenas

Andrew Vaitekenas

Honours Student

Reports and Findings

Show all

Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models

Mutation-agnostic treatments such as airway gene therapy have the potential to treat any individual with cystic fibrosis (CF), irrespective of their CF transmembrane conductance regulator (CFTR) gene variants. The aim of this study was to employ two CF rat models, Phe508del and CFTR knockout to assess the comparative effectiveness of CFTR modulators and lentiviral vector-mediated gene therapy. 

Transcriptomic analysis of primary nasal epithelial cells reveals altered interferon signalling in preterm birth survivors at one year of age

Many survivors of preterm birth (<37 weeks gestation) have lifelong respiratory deficits, the drivers of which remain unknown. Influencers of pathophysiological outcomes are often detectable at the gene level and pinpointing these differences can help guide targeted research and interventions. This study provides the first transcriptomic analysis of primary nasal airway epithelial cells in survivors of preterm birth at approximately 1 year of age.

Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia

Acinetobacter baumannii is a common pathogen associated with hospital-acquired pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays. Infections with A. baumannii cause high patient fatalities due to their capability to evade current antimicrobial therapies, emphasizing the urgency of developing viable therapeutics to treat A. baumannii-associated pneumonia.

The respiratory health effects of acute in vivo diesel and biodiesel exhaust in a mouse model

Biodiesel, a renewable diesel fuel that can be created from almost any natural fat or oil, is promoted as a greener and healthier alternative to commercial mineral diesel without the supporting experimental data to back these claims. The aim of this research was to assess the health effects of acute exposure to two types of biodiesel exhaust, or mineral diesel exhaust or air as a control in mice.

Show all